Their observed downregulation in severe COVID-19 cases influences the production of IRAK1 (interleukin-1 receptor-associated kinase), IRAK2 and TRAF6 (tumor necrosis factor receptor-associated factor 6) in immune cells. This evidence concerns the gene IRAK1 and COVID-19.